Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Brian, Hennessy"'
Publikováno v:
Clinical Case Reports, Vol 11, Iss 5, Pp n/a-n/a (2023)
Key Clinical Message We present a case of Bing–Neel syndrome a rare central nervous system lymphoplasmocytic lymphoma associated with Waldenstrom macroglobulinemia. Diagnosis should be considered in the context of unexplained neurological symptoms
Externí odkaz:
https://doaj.org/article/a4e6b936d3ad4787acfcee8667618c84
Autor:
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, Tatiana Sidorenko, Neli Boyanova, Anne Brooks, Brian Hennessy, Carol Jamieson, Bennett Levitan
Publikováno v:
Multiple Sclerosis Journal. 29:427-435
Background: In the OPTIMUM trial in patients with relapsing MS, treatment differences in annualized relapse rate (ARR, 0.088) and change in fatigue at week 108 (3.57 points, measured using the Fatigue Symptoms and Impacts Questionnaire–Relapsing Mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d602eb0fac26b1a01d68c1caeb0452
https://doi.org/10.1177/13524585221140270
https://doi.org/10.1177/13524585221140270
Autor:
Mark S, Freedman, Carlo, Pozzilli, Eva Kubala, Havrdova, Alexandre, Lemle, Michel, Burcklen, Anna, Larbalestier, Brian, Hennessy, Tatiana, Sidorenko, Andrea, Vaclavkova, Tomas, Olsson
Publikováno v:
Neurology. 99:e762-e774
ObjectiveTo evaluate the dose-response relationship of 10, 20, and 40 mg ponesimod and long-term efficacy and safety of ponesimod 20 mg using an analysis of combined data from the phase 2 Core and Extension studies in patients with relapsing-remittin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4ac00dbb03653b5ac76c9cf9253087
https://doi.org/10.1212/wnl.0000000000200606
https://doi.org/10.1212/wnl.0000000000200606
Here we present a diagnostically challenging Bing-Neel Syndrome (BNS) case successfully treated with systemic chemoimmunotherapy and ibrutinib, with remarkable clinical response. BNS is an extremely rare direct central nervous system infiltration by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf09f976a41716ccab22750824642e6d
https://doi.org/10.22541/au.167419288.80264053/v1
https://doi.org/10.22541/au.167419288.80264053/v1
Autor:
David Jackson, Anthony G Ryan, Elaine Walsh, Mark Bolger, Brian Hennessy, Ezzat ElHassadi, Senthil Kumar, Joan Heneghan, Donal O'Driscoll
Publikováno v:
BJR|case reports. 8
Lymphomas are a heterogenous group of cancers of the lymphatic system in which disease primarily arises in lymph nodes. Extranodal disease is common; however, musculoskeletal involvement is rare. Imaging plays an important role in the diagnosis and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d11cb96e34c5a8b7b8c6157f8a0bcdf
https://doi.org/10.1259/bjrcr.20210182
https://doi.org/10.1259/bjrcr.20210182
Autor:
Robert B. Henderson, Brian Hennessy, Christopher L. Bacon, Patrick Thornton, Richard Flavin, David O'Brien, Fiona Quinn, Hilary O'Leary, Anita Dowling, Michael O'Dwyer, Helen Fogarty, Steve Langabeer, James Nolan, Elisabeth Vandenberghe, Gerard Crotty
Publikováno v:
Irish Journal of Medical Science (1971 -). 190:1087-1094
Introduction Biclonal lymphoid disorders, when two distinct lymphoproliferative disorders (LPD) co-exist, are rare (incidence of 1.4%) and associated with a poor prognosis. NOTCH1 mutations occur in 10% of CLL at diagnosis, associated with a short di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3d0a20d88069b7bf1d426b723e33c97
https://doi.org/10.1007/s11845-020-02386-1
https://doi.org/10.1007/s11845-020-02386-1
Autor:
Tommi Tervonen, Robert J Fox, Anne Brooks, Tatiana Sidorenko, Neli Boyanova, Bennett Levitan, Brian Hennessy, Andrea Phillips-Beyer
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9:205521732211503
Background Treatment decisions for multiple sclerosis (MS) are influenced by many factors such as disease symptoms, comorbidities, and tolerability. Objective To determine how much relapsing MS patients were willing to accept the worsening of certain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0918f51fbcd1f89137566ce6d9529d44
https://doi.org/10.1177/20552173221150370
https://doi.org/10.1177/20552173221150370
Publikováno v:
Irish Journal of Medical Science (1971 -). 190:1239-1241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d57b4e108fa96a8ca092b275f095da
https://doi.org/10.1007/s11845-020-02418-w
https://doi.org/10.1007/s11845-020-02418-w
Publikováno v:
Multiple Sclerosis and Related Disorders. 64:103908
Multiple sclerosis (MS) is an inflammatory autoimmune disorder and the most common cause of non-traumatic disability in young adults. The Phase 3 OPTIMUM study evaluated the efficacy and safety of oral ponesimod, a selective sphingosine-1-phosphate (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa83bae318c251c8b18b83d3cef85cf
https://doi.org/10.1016/j.msard.2022.103908
https://doi.org/10.1016/j.msard.2022.103908
Autor:
Rachel Lacey, Dearbhla Doherty, Jonathan Miller, Pamela McKay, Heather Leary, Tim Ebsworth, Mark Bishton, Ruth Clifford, Nicholas Denny, Clodagh Keohane, Oliver Lomas, Nicolas Martinez-Calle, Graeme Ferguson, Rachael Pocock, Nagah Elmusharaf, Jonathan Lambert, Amjad Hayat, Alexandros Rampotas, Matthew R. Wilson, Toby A. Eyre, Rehman Faryal, Angharad Everden, Helen Marr, Ezzat El-Hassad, Steve Prideaux, Adam Gibb, Brian Hennessy, Nimish Shah, David Tucker
Publikováno v:
British journal of haematologyReferences. 194(2)
Mantle cell lymphoma (MCL) presenting in elderly, unfit patients represents a clinical challenge. Front-line 'attenuated' or low-intensity immunochemotherapy is often employed, although outcomes are relatively unexplored. We report outcomes of attenu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45329a32f7c7b8d54694981c0d3f550
https://pubmed.ncbi.nlm.nih.gov/33959947
https://pubmed.ncbi.nlm.nih.gov/33959947